Teladoc Health, Inc. TDOC
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.47B | 2.49B | 2.51B | 2.53B | 2.53B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.47B | 2.49B | 2.51B | 2.53B | 2.53B |
| Cost of Revenue | 775.67M | 772.59M | 772.29M | 771.59M | 763.47M |
| Gross Profit | 1.69B | 1.72B | 1.74B | 1.76B | 1.76B |
| SG&A Expenses | 1.19B | 1.23B | 1.26B | 1.28B | 1.30B |
| Depreciation & Amortization | 368.51M | 366.41M | 368.50M | 364.08M | 358.76M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.60B | 2.64B | 2.67B | 2.69B | 2.71B |
| Operating Income | -132.33M | -145.65M | -157.19M | -163.40M | -178.59M |
| Income Before Tax | -158.65M | -182.59M | -185.11M | -235.53M | -250.08M |
| Income Tax Expenses | -3.83M | -5.20M | -13.96M | -35.21M | -26.50M |
| Earnings from Continuing Operations | -154.82 | -177.40 | -171.15 | -200.32 | -223.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -154.82M | -177.40M | -171.15M | -200.32M | -223.59M |
| EBIT | -132.33M | -145.65M | -157.19M | -163.40M | -178.59M |
| EBITDA | 85.54M | 64.56M | 47.51M | 33.06M | 16.17M |
| EPS Basic | -0.86 | -0.99 | -0.96 | -1.14 | -1.28 |
| Normalized Basic EPS | -0.44 | -0.49 | -0.49 | -0.48 | -0.55 |
| EPS Diluted | -0.86 | -0.99 | -0.96 | -1.14 | -1.28 |
| Normalized Diluted EPS | -0.44 | -0.49 | -0.49 | -0.48 | -0.55 |
| Average Basic Shares Outstanding | 719.86M | 714.91M | 709.81M | 704.84M | 699.77M |
| Average Diluted Shares Outstanding | 719.86M | 714.91M | 709.81M | 704.84M | 699.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |